CYTOSORBENTS CORPORATION
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.5M | $-11.8M | $-9.5M | $-9.3M | $-4.7M | $-3.7M | $-5.5M | $-2.9M |
| Depreciation & Amortization | $218.3K | $161.6K | $113.0K | $65.5K | $64.4K | $54.6K | $39.2K | $17.8K |
| Depreciation | $177.8K | $126.1K | $87.4K | $48.4K | $39.9K | $29.3K | $23.8K | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.3M | $2.8M | $382.3K | $695.8K | $456.9K | — | — | — |
| Net Cash from Operating Activities | $-6.5M | $-6.7M | $-9.0M | $-6.7M | $-3.5M | $-3.6M | $-3.8M | $-2.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $990.7K | $140.7K | $403.6K | $153.2K | $38.7K | $19.9K | $34.7K | $139.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.7M | $1.6M | $-890.9K | $-2.3M | $-216.4K | $-38.8K | $-52.5K | $-165.4K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $20.1M | $5.1M | $11.6M | $10.0M | $4.2M | $4.2M | $4.0M | $2.1M |
| Net Change in Cash | $12.1M | $-71.7K | $1.7M | $1.4M | $453.7K | $542.7K | $131.0K | $-540.0K |
| Free Cash Flow | $-7.5M | $-6.9M | $-9.5M | $-6.8M | $-3.5M | $-3.6M | $-3.9M | $-2.6M |